Sign up to our newsletter Subscribe
Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective

We have established an excellent reputation for leading innovative, ideas-driven, and theoretically sound research on the measurement and valuation of outcomes. Health care systems should put patient-relevant outcomes at the heart of decisions about funding and providing health and social care.